| Darryl Johnson, | |
|
7457 Harwin Dr Ste 210, Houston, TX 77036-2024 | |
| (832) 573-9016 | |
| Not Available |
| Full Name | Darryl Johnson |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology - Clinical & Laboratory Immunology |
| Location | 7457 Harwin Dr Ste 210, Houston, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790107977 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KI0005X | Allergy & Immunology - Clinical & Laboratory Immunology | N5626 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Darryl Johnson, 7457 Harwin Dr Ste 210, Houston, TX 77036-2024 Ph: (832) 573-9016 | Darryl Johnson, 7457 Harwin Dr Ste 210, Houston, TX 77036-2024 Ph: (832) 573-9016 |
News Archive
Zytoprotec, a company developing drugs based on active cytoprotection, today announced the completion of a Phase I/II clinical trial with its lead product, PD-protec™. The product is developed to improve the treatment of patients with kidney failure.
A neuroimaging study suggests that patients with schizophrenia have difficulty deactivating the default mode network, rather than having increased absolute metabolic activity.
In an article in the Medical Law Review, Dr Kirsty Horsey, of the University of Kent, describes cases that show current surrogacy law in the UK is 'fraying at the edges'.
Researchers from North Carolina State University have developed a de facto antibiotic "smart bomb" that can identify specific strains of bacteria and sever their DNA, eliminating the infection. The technique offers a potential approach to treat infections by multi-drug resistant bacteria.
Transition Therapeutics Inc. announced today that the first patient has been dosed with drug candidate TT-301 in a Phase 1 clinical study. TT-301 is a small molecule compound that has demonstrated efficacy in preclinical models of rheumatoid arthritis, intracerebral haemorrhage and traumatic brain injury.
› Verified 6 days ago
Dr. Joud Hajjar, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 7009 Almeda Rd Apt 1325, Houston, TX 77054 Phone: 804-937-1662 | |
Ekta K Perera, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6410 Fannin St Fl 6, Houston, TX 77030 Phone: 713-500-6876 | |
Naureen Alim, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6550 Fannin St Ste 2421, Houston, TX 77030 Phone: 281-888-9870 Fax: 713-422-2336 | |
Dr. Leonard S. Hoffman, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 902 Frostwood Dr, 302, Houston, TX 77024 Phone: 713-973-0051 Fax: 713-973-7130 | |
Theodore Lee, Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 17203 Red Oak Dr Ste 101, Houston, TX 77090 Phone: 281-886-7440 | |
Tina Motazedi, Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6550 Fannin St Ste 1101, Houston, TX 77030 Phone: 713-441-3992 | |
Dr. Derrick Wayne Ratcliff Jr., Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 14405 Walters Rd, Houston, TX 77014 Phone: 346-360-6478 |